MAPT and Alzheimer disease: To assess tau pathology in the brains of P301S+/− and P301S+/−,KIF5B+/− mice, we used AT8, AT100, AT180, and PHF1 monoclonal antibodies, which are commonly used as diagnostic markers of Alzheimer’s disease.